SKORPIOS TRUST
Q4 2021 Form 13-F
LIMASSOL, CYPRUS
CIK 0001869333
· Institutional investment manager
$451.9M Reported Value Total
Reported value
$451.9M
Quarter over quarter
0.0%
Holdings
5
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Androulla Papadopoulou
Director
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2021 13F record
Q4 2021 13F filing summary
| Period of report | December 31, 2021 |
|---|---|
| Filed | January 27, 2022 |
| Form | 13F-HR |
| Reported value | $451.9M |
| Positions | 5 |
| Change in reported value | First reported quarter |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2025 13F
Filed Oct 29, 2025
|
2 | $53.2M |
|
Q2 2025 13F
Filed Jul 30, 2025
|
2 | $37.1M |
|
Q1 2025 13F
Filed May 6, 2025
|
2 | $46.1M |
|
Q4 2024 13F
Filed Feb 5, 2025
|
2 | $76.3M |
|
Q3 2024 13F
Filed Oct 23, 2024
|
2 | $109.6M |
|
Q2 2024 13F
Filed Aug 5, 2024
|
2 | $146.7M |
|
Q1 2024 13F
Filed Apr 26, 2024
|
2 | $195.1M |
|
Q4 2023 13F
Filed Feb 6, 2024
|
2 | $76.1M |
|
Q3 2023 13F
Filed Nov 6, 2023
|
2 | $57.0M |
|
Q2 2023 13F
Filed Aug 3, 2023
|
4 | $230.3M |
|
Q1 2023 13F
Filed May 15, 2023
|
4 | $247.5M |
|
Q4 2022 13F
Filed Feb 7, 2023
|
4 | $314.4M |
|
Q3 2022 13F
Filed Nov 7, 2022
|
4 | $354.3M |
|
Q2 2022 13F
Filed Aug 2, 2022
|
4 | $239.0M |
|
Q1 2022 13F
Filed Apr 22, 2022
|
4 | $375.6M |
|
Q4 2021 13F
Filed Jan 27, 2022
|
5 | $451.9M |
Top 5 holdings · Q4 2021
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | STOK STOKE THERAPEUTICS INC | $346.5M | 76.67% |
| 2 | AKRO AKERO THERAPEUTICS INC | $103.8M | 22.97% |
| 3 | ATVI ACTIVISION BLIZZARD INC | $1.4M | 0.32% |
| 4 | XBI SPDR SER TR | $189.0K | 0.04% |
| 5 | OGN ORGANON & CO | $16.0K | < 0.01% |
Values as reported on the Q4 2021 Form 13F. Every position is in the holdings table below.